CN Patent

CN110812325B — 一种提高酮咯酸氨丁三醇注射液存储稳定性的方法

Assigned to Lunan Pharmaceutical Group Corp · Expires 2022-04-05 · 4y expired

What this patent protects

本发明属于医药制剂技术领域，具体涉及一种提高酮咯酸氨丁三醇注射液存储稳定性的方法。本发明将制备好的酮咯酸氨丁三醇注射液灌装于聚丙烯塑料安瓿或环烯烃聚合物塑料瓶中，解决了酮咯酸氨丁三醇注射液长期放置过程中注射液容易产生白色小点，从而导致可见异物不合格的问题，不溶性微粒较少，质量稳定。

USPTO Abstract

本发明属于医药制剂技术领域，具体涉及一种提高酮咯酸氨丁三醇注射液存储稳定性的方法。本发明将制备好的酮咯酸氨丁三醇注射液灌装于聚丙烯塑料安瓿或环烯烃聚合物塑料瓶中，解决了酮咯酸氨丁三醇注射液长期放置过程中注射液容易产生白色小点，从而导致可见异物不合格的问题，不溶性微粒较少，质量稳定。

Drugs covered by this patent

Patent Metadata

Patent number
CN110812325B
Jurisdiction
CN
Classification
—
Expires
2022-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Lunan Pharmaceutical Group Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.